LINCOLNTON, N.C., March 23, 2016 -- Carolina Trust Bank (Nasdaq:CART) announced today that it revised its unaudited financial results for the year ended December 31, 2015 and reported the Bank earned net income available to common shareholders of $824,000 or $0.18 per diluted common share in comparison to unaudited results of $1,042,000 or $0.22 per diluted common share originally reported on January 25, 2016. Before payment of dividends on preferred shares, the Bank earned $1,058,000 in comparison to the $1,276,000 previously reported for the year ended December 31, 2015. The revised financial statements are primarily the result of a change in the discount rate used to account for the Bank’s Supplemental Retirement Plan (“SERP”) as well as the write-off of an expired net operating loss carry forward relating to the Carolina Commerce Bank acquisition in the Bank’s deferred tax asset balance as of December 31, 2015. Complete financial results for the year ended December 31, 2015 are reported in the Bank’s Form 10-K and Annual Report that were filed today.
A copy of the Bank’s Form 10-K and Annual Report may be obtained by contacting the FDIC in writing at FDIC, Accounting and Securities Disclosure Section, 550 17th Street, NW, Washington, DC 20429, or by email at [email protected].
About Carolina Trust Bank
Carolina Trust Bank is a full service state chartered bank headquartered in Lincolnton, N.C., operating nine full service branches in Lincoln, Catawba, Gaston and Rutherford Counties in western North Carolina and a loan production office in Mooresville, N.C.
Contact: Jerry L. Ocheltree President and CEO Carolina Trust Bank (704) 735-1104


Instagram Outage Disrupts Thousands of U.S. Users
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



